The use of PDX mouse models to test the effectiveness of anti‐cytokine or anti‐chemokine antibodies (such as anti‐IL6 antibody) in reducing tumor growth is likely to become prevalent and our results suggest a note of caution in the design and interpretation of these studies. Here, IL6 is linked to neoplasm.